Medpace Holdings, Inc.

MEDP Healthcare Diagnostics & Research

Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.

Revenue
+8.50%
EPS
+24.6%
Free cash flow
−16.6%

Quarter to September 2026, against a year earlier

634.63 22.14 −3.37%
Market cap
$17.8B
P/E
34.6×
Fwd P/E
35.8×
Dividend yield
—
F-score
8/9
Altman Z
8.04
Beneish M
−2.92
Dividend safety
n/a

Medpace Holdings, Inc. (MEDP) Operating cash flow

Alert me on Operating cash flow

Medpace Holdings, Inc.'s operating cash flow for fiscal 2025 was $713.2M, up 17.1% from $608.8M in fiscal 2024. Over the twelve months to 30 September 2026 it was $723.0M. Over the past ten years it has ranged from $85.9M (fiscal 2015) to $713.2M (fiscal 2025) — the current reading is the highest in ten years. Operating cash flow has risen for 10 consecutive fiscal years. Medpace Holdings, Inc. ranks 11th of 49 Diagnostics & Research companies by operating cash flow.

Operating cash flow, annual

Embed this chart

Annual newest first

Period Operating cash flow Change
FY2025 $713.2M 17.15%
FY2024 $608.8M 40.48%
FY2023 $433.4M 11.68%
FY2022 $388.1M 47.36%
FY2021 $263.3M 1.80%
FY2020 $258.7M 28.14%
FY2019 $201.9M 28.92%
FY2018 $156.6M 60.79%
FY2017 $97.4M 6.16%
FY2016 $91.7M 6.83%

Quarterly newest first

Period Operating cash flow Change
Sep 2026 $216.6M 33.69%
Jun 2026 $162.0M 6.74%
Mar 2026 $151.8M (21.21%)
Dec 2025 $192.7M (21.75%)
41 more quarters

Against its own ten years

Low $85.9M High $713.2M
Ten-year median $258.7M
Current reading's percentile 100

Operating cash flow against peers

What Operating cash flow is

Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.

Reported line item

The full definition of Operating cash flow →

More on MEDP